MARSHALL WACE, LLP – Vertex Pharmaceuticals Incorporated Transaction History
MARSHALL WACE, LLP portfolio value:
$79.29M
portfolio value
MARSHALL WACE, LLP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -29.99% | -117.3K shares | -30.93M | $289.54 | 273.85K |
Q2 2022 | share | Increase | 0.00% | 391.15K shares | 110.22M | $281.79 | 391.15K |
Q1 2022 | share | Decrease | -100.00% | -150K shares | -32.94M | $260.97 | 0 |
Q4 2021 | share | Decrease | -73.05% | -406.67K shares | -68.03M | $222.45 | 150K |
Q3 2021 | share | Increase | +1.04% | 5.71K shares | -10.11M | $181.39 | 556.67K |
Q2 2021 | share | Increase | +195.06% | 364.23K shares | 70.96M | $201.63 | 550.95K |
Q1 2021 | share | Decrease | -6.44% | -12.85K shares | -7.04M | $214.89 | 186.72K |
Q4 2020 | share | Increase | +381.30% | 158.11K shares | 35.88M | $236.34 | 199.58K |
Q3 2020 | share | Increase | +797.19% | 36.84K shares | 9.94M | $272.12 | 41.46K |
Q2 2020 | share | Increase | +622.19% | 3.98K shares | 1.19M | $290.31 | 4.62K |
Q1 2020 | share | Decrease | -98.29% | -36.88K shares | -8.06M | $237.95 | 640 |
Q4 2019 | share | Decrease | -48.99% | -36.03K shares | -4.24M | $218.95 | 37.52K |
Q3 2019 | share | Decrease | -20.29% | -18.72K shares | -4.46M | $169.42 | 73.55K |
Q2 2019 | share | Increase | +48.29% | 30.05K shares | 5.47M | $183.38 | 92.28K |
Q1 2019 | share | Increase | +1.09% | 672 shares | 1.24M | $183.95 | 62.23K |
Q4 2018 | share | Decrease | -66.69% | -123.25K shares | -25.42M | $165.71 | 61.56K |
Q3 2018 | share | Decrease | -50.91% | -191.67K shares | -28.36M | $192.74 | 184.81K |
Q2 2018 | share | Increase | +1027.50% | 343.09K shares | 58.54M | $169.96 | 376.48K |
Q1 2018 | share | Decrease | -69.83% | -77.27K shares | -11.14M | $162.98 | 33.39K |
Q4 2017 | share | Increase | +413.12% | 89.09K shares | 13.30M | $149.86 | 110.66K |
Q3 2017 | share | Decrease | -55.83% | -27.26K shares | -3.02M | $152.04 | 21.56K |
Q2 2017 | share | Increase | 0.00% | 48.83K shares | 6.29M | $128.87 | 48.83K |
Q1 2016 | share | Decrease | -100.00% | -241.82K shares | -30.42M | $79.49 | 0 |